Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon therapy for ocular disease.

Friederike Mackensen1, Regina Max, Matthias D Becker

  • 1Department of Ophthalmology, Interdisciplinary Uveitis Center, University of Heidelberg, Germany.

Current Opinion in Ophthalmology
|October 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of patient-reported outcome measures in everyday clinical practice in ophthalmology: results of a European multicountry survey.

The British journal of ophthalmology·2025
Same author

The reproducibility of handheld ERGs recorded with skin electrode and natural pupils.

Documenta ophthalmologica. Advances in ophthalmology·2025
Same author

Comparison of treatment routine using aflibercept: Strict vs. relaxed retreatment regimen (TOLERANT study)-A non-inferiority, randomized controlled trial.

Acta ophthalmologica·2025
Same author

Treatment of Uveal Melanoma Using a Novel Radiosurgical Platform: A Case Report.

Cureus·2025
Same author

[Open Globe Injury Caused by an Eyelash Curler in a Beautician].

Klinische Monatsblatter fur Augenheilkunde·2025
Same author

Real-Time Integration of Optical Coherence Tomography Thickness Map Overlays for Enhanced Visualization in Epiretinal Membrane Surgery: A Pilot Study.

Bioengineering (Basel, Switzerland)·2025
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Type 1 interferons show promise in treating ocular diseases like Behçet disease and multiple sclerosis-associated uveitis. Further research is needed to confirm their efficacy and understand their therapeutic mechanisms in eye conditions.

Area of Science:

  • Ophthalmology
  • Immunology
  • Pharmacology

Background:

  • Interferons (IFNs) are cytokines initially recognized for antiviral properties.
  • Immunomodulatory therapies utilizing IFNs have been explored across various medical conditions.
  • Type 1 interferons are investigated for their therapeutic potential in ophthalmic diseases.

Purpose of the Study:

  • To review the role of type 1 interferons in treating ocular diseases.
  • To summarize the presumed mechanisms of action for these therapies.
  • To highlight emerging applications in ophthalmology.

Main Methods:

  • Literature review of studies on interferon therapy in ocular conditions.
  • Analysis of preliminary data on clinical outcomes.

Related Experiment Videos

  • Examination of proposed mechanisms of action.

    • Main Results:

    • Interferons demonstrate beneficial effects in Behçet disease and multiple sclerosis-associated uveitis, improving visual acuity and reducing inflammation.
    • Topical interferon application shows potential as an adjuvant therapy for viral keratitis and ocular surface malignancies.
    • Preliminary data suggest improvements in intraocular inflammation and chronic macular edema.

    Conclusions:

    • Interferons are emerging as a valuable treatment option for specific ocular diseases.
    • Evidence supports their potential in managing ocular Behçet disease and MS-associated uveitis.
    • Randomized controlled trials are essential to validate these findings and further elucidate interferon mechanisms in ocular therapeutics.